Robert M. Gray

Represented Novonesis on its agreement to acquire dsm-firmenich’s share of the Feed Enzyme Alliance for EUR 1.5 billion.

Represented Archer Daniels Midland on its acquisition of Vandamme Hungaria and related group entities.

Represented Novonesis on the global carve-out and sale of its lactase business to Kerry Group PLC.

Represented Chr. Hansen A/S on its EUR 12 billion merger with Novozymes.

Represented numerous US and European corporations on all aspects of their exit from the Russian market, including on corporate, commercial and sanctions considerations.

Represented Baker Hughes on the global carve-out and sale of its Nexus Controls business to GE.

Represented Chr. Hansen A/S on the global carve-out and sale of its Natural Colors Division.

Represented Emerson Electric Company on the carve-out and sale of its Therm-o-Disc business to One Rock Capital Partners.

Representing GSK on the establishment of its consumer healthcare joint venture with Pfizer.

Represented Ecolab, Inc. on its acquisition of online training provider, Lobster Ink.

Represented Zebra Technologies Corporation on it acquisition of Cortexica Vision Systems.

Represented Emerson Electric Company on its USD 3.15 billion acquisition of the valves and controls business of Pentair plc.

Represented Emerson Electric Company on its acquisition of GE's Intelligent Platforms Business.

Represented W.R. Grace & Co., a NYSE listed chemical production company, on the international carve-out and spin-off of its USD 1.5 billion GCP Construction Producs business.

Advised GCP Applied Technologies on its USD 1 billion disposal of its Darex Brand to Henkel AG.

Represented Archer Daniels Midland on the establishment of its Rostov-on-Don based joint venture with Russian agricultural group, Aston.